Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma.
Year of publication
2019
Authors
Auvray M; Auclin E; Barthelemy P; et al; Kellokumpu-Lehtinen P
Organizations and authors
Tampere University Hospital Catchment Area
Kellokumpu-Lehtinen Pirkko-Liisa
Publication type
Publication format
Article
Parent publication type
Journal
Article type
Original article
Audience
ScientificPeer-reviewed
Peer-ReviewedMINEDU's publication type classification code
A1 Journal article (refereed), original researchPublication channel information
Journal
Volume
108
Pages
33-40
ISSN
Publication forum
Publication forum level
2
Open access
Open access in the publisher’s service
No information
Self-archived
No
Other information
Fields of science
Cancers
Internationality of the publisher
International
International co-publication
Yes
Co-publication with a company
No
The publication is included in the Ministry of Education and Culture’s Publication data collection
Yes